MOVE Medacta Group SA

122.22USD103.00 CHF · SWX-1.72%Mkt Cap: 2.44B USDP/E: 28.77

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools f…

Institutional holders10 on file

Key Statistics

Company
Market Cap2.44B USD
Enterprise Value2.78B USD
Revenue (TTM)776.37M USD
Gross Profit503.06M USD
Net Income (TTM)104.70M USD
Revenue/Share38.96 USD
Last Price122.22 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.3K
CountryCH
SectorHealthcare
IndustryMedical Devices
ISINCH0468525222
Valuation
P/E (Trailing)28.77
P/E (Forward)20.23
PEG—
EV/EBITDA13.72
EV/Revenue3.58
P/S2.90
P/B4.59
EPS (TTM)3.93 USD
EPS (Forward)5.58 USD
52W Range
121.511% of range210.27
52W High210.27 USD
52W Low121.51 USD
Profitability
Gross Margin67.07%
Oper. Margin15.19%
EBITDA Margin24.09%
Profit Margin13.96%
ROE20.91%
ROA10.40%
ROIC13.48%
ROCE15.89%
Growth
Revenue Growth7.00%
Earnings Growth-30.20%
Cash Flow & Leverage
Operating CF167.43M USD
CapEx (TTM)156.95M USD
FCF Margin-7.13%
FCF Yield-2.27%
Net Debt312.14M USD
Net Debt/EBITDA1.67
Net Debt/FCF—
Balance Sheet
Debt/Equity0.57
Current Ratio2.10
Quick Ratio0.74
Book Value/Sh24.60 USD
Cash/Share1.98 USD
Dividends
Fwd Div Rate1.31 USD
Trail. Div Rate1.40 USD
Div. Yield1.05%
5Y Avg Yield0.40%
Payout Ratio30.59%
Ex-Div DateMay 7, 2026
Pay DateMay 13, 2025
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)177.83 USD
Upside (mean)+45.5%
Target Range134.63 USD – 209.58 USD
134.63+45.5% to mean209.58
# Analysts6
Ownership
Shares Out.19.95M
Float6.03M
Insiders69.66%
Institutions13.84%
Technical
SMA 50135.29 (-9.7%)
SMA 200159.90 (-23.6%)
Beta0.95
S&P 52W Chg12.00%
Avg Vol (30d)34.27K
Avg Vol (10d)50.44K
Technical Indicators
RSI (14)31.1
MACD-3.2903
MACD Signal-2.0582
MACD Hist.-1.2322
BB Upper151.16 USD
BB Middle134.69 USD
BB Lower118.22 USD
BB Width24.46%
ATR (14)4.132 USD
Vol Ratio (20d)0.76x

About Medacta Group (SWX: MOVE)

›

Medacta Group (SWX: MOVE) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 2,273 employees.

The shares were at 103.00 CHF on 19 November 2026, down 30.8% over 52 weeks. Its 52-week range is 102.40 CHF to 177.20 CHF, and it trades at the bottom of that range.

At a market capitalisation of 2.05B CHF, it trades at 28.8 times trailing earnings and 20.2 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a premium of 12% for MOVE. It pays a dividend yielding 1.05% (it pays out 31% of its earnings), against a median of 2.36% among the dividend payers in that peer group.

Medacta Group reports return on equity of 20.9%, an operating margin of 15.2% and revenue up 7.0% year over year.

Its debt exceeds its cash by 284.59M EUR, a debt-to-equity ratio of 0.57. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 6 analysts cover the stock, with an average rating of Buy; their mean price target of 149.86 CHF is 45.5% above the current price. The next earnings report is expected on 10 March 2027.